<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00906646</url>
  </required_header>
  <id_info>
    <org_study_id>91/04</org_study_id>
    <nct_id>NCT00906646</nct_id>
  </id_info>
  <brief_title>Preparation of Patients for Cardiac Surgery</brief_title>
  <acronym>MPM</acronym>
  <official_title>Preparation of Patients for Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bayside Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Griffith University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bayside Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This was a prospective randomised trial of metabolic therapy including antioxidants and
      cellular energisers to determine whether this therapy could improve the results of cardiac
      surgery. The hypothesis was that the metabolic therapy could improve clinical recovery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective Perioperative therapy with antioxidants and metabolic substrates has the potential
      to reduce oxidative stress and improve recovery from cardiac surgery, particularly in elderly
      and high risk cases. The aim of the study was to assess the effect of perioperative metabolic
      therapy at a biochemical and clinical level in cardiac surgical patients.

      Methods Patients (n = 117, mean age 65 ± 1.0 years, 74% male) undergoing elective coronary
      artery bypass graft (CABG) and/or valve surgery were randomized to receive for a minimum of 2
      weeks before and one month after surgery, either metabolic therapy (coenzyme Q10, magnesium
      orotate, lipoic acid, omega-3 fatty acids and selenium) or placebo. Biochemical and clinical
      outcomes were assessed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2004</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">June 2006</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Troponin release</measure>
    <time_frame>24 hours after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of atrial fibrillation</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">117</enrollment>
  <condition>Coronary Artery Bypass Graft Surgery</condition>
  <condition>Cardiac Valve Surgery</condition>
  <arm_group>
    <arm_group_label>Metabolic therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Metabolic therapy with antioxidants and cellular energisers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo tablets</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Metabolic therapy</intervention_name>
    <description>Coenzyme Q10 - 100 mg tds Magnesium orotate - 400 mg tds Lipoic acid - 100 mg tds Omega-3 fatty acids - 300 mg (in 1 g fish oils) tds Selenium - 200 µg</description>
    <arm_group_label>Metabolic therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo tablets</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing elective coronary artery bypass graft (CABG) and/or valve surgery

        Exclusion Criteria:

          -  urgent or emergency surgery

          -  NYHA class IV heart failure

          -  taken antioxidant supplements in the previous month
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Franklin L Rosenfeldt, MBBS, MD</last_name>
    <role>Study Director</role>
    <affiliation>The Alfred</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Alfred Hospital</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>May 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 20, 2009</study_first_submitted>
  <study_first_submitted_qc>May 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2009</study_first_posted>
  <last_update_submitted>May 20, 2009</last_update_submitted>
  <last_update_submitted_qc>May 20, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 21, 2009</last_update_posted>
  <responsible_party>
    <name_title>Professor Franklin Rosenfeldt</name_title>
    <organization>Alfred Hospital</organization>
  </responsible_party>
  <keyword>cardiac</keyword>
  <keyword>surgery</keyword>
  <keyword>metabolic</keyword>
  <keyword>supplements</keyword>
  <keyword>antioxidant</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antioxidants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

